3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)propan-1-one | 527750-78-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)propan-1-one
• CAS: 527750-78-3
• 化学式: C₁₉H₂₂O₆
• 分子量: 346.38
• InChiKey: FTBQBXAQUYUVKD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  25
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  74.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)propan-1-one 在 palladium on activated charcoal 、 氢气 、 溶剂黄146 作用下， 以91.4 %的产率得到2-methoxy-5-<3-(3,4,5-trimethoxyphenyl)propyl>phenol
  参考文献：
  名称：

  毛兰素类似物作为肝癌细胞丙酮酸羧化酶抑制剂的设计、合成及构效关系研究

  摘要：

  基于生物等排原理，通过改变毛兰素的两个芳香环、环上的取代基以及环上的连接基，设计合成了一系列新型毛兰素类似物。该类似物在肝细胞癌细胞中作为丙酮酸羧化酶 (PC) 抑制剂进行了评估。结果发现，用氟取代羟基的化合物35和36在肝癌细胞中表现出比毛兰素更高的活性（IC 50值为17.30 nM），IC 50值分别为15.15 nM和10.05 nM。此外，在10 nM浓度下，化合物35和36对PC的抑制率分别为39.10%和40.15%，表现出与毛兰素几乎相同的抑制活性（抑制率为40.07%）。此外，计算机模拟对接研究证明了受体和配体之间更好相互作用的基础。35的氟原子不仅可以与Lys-1043（NH⋯F，2.04 Å）形成氢键，还可以与Lys-1043（3.67 Å）和Glu-1046（3.70 Å）的羰基形成氟键，由于B环弹头上的卤素的取向不同。相反， 34的氯原子只能与Lys-1043中的

  DOI：

  10.1039/d3ob01114c
• 作为产物：
  描述：

  3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)pr op-2-en-1-one 在 ammonium acetate 、 锌 作用下， 以 乙醇 、 水 为溶剂， 反应 1.0h， 以75%的产率得到3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)propan-1-one
  参考文献：
  名称：

  Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities

  摘要：

  Chalcone is a privileged structure, demonstrating promising anti-inflammatory and anticancer activities. One potential mechanism is to suppress nuclear factor kappa B (NF-kappa B) activation. The structures of chalcone-based NF-kappa B inhibitors vary significantly that there is minimum information about their structure-activity relationships (SAR). This study aims to establish SAR of chalcone-based compounds to NF-kappa B inhibition, to explore the feasibility of developing simple chalcone-based potent NF-kappa B inhibitors, and to evaluate their anticancer activities. Three series of chalcones were synthesized in one to three steps with the key step being aldol condensation. These candidates demonstrated a wide range of NF-kappa B inhibitory activities, some of low micromolar potency, establishing that structural complexity is not required for NF-kappa B inhibition. Lead compounds also demonstrate potent cytotoxicity against lung cancer cells. Their cytotoxicities correlate moderately well with their NF-kappa B inhibitory activities, suggesting that suppressing NF-kappa B activation is likely responsible for at least some of the cytotoxicities. One lead compound effectively inhibits lung tumor growth with no signs of adverse side effects.

  DOI：

  10.1021/jm901278z

文献信息

• 毛兰素类似物及其合成方法和应用
  申请人：中国科学院成都生物研究所

  公开号：CN116535304A

  公开（公告）日：2023-08-04

  本发明属于化合物合成领域，具体涉及毛兰素类似物及其合成方法和应用。具体技术方案为：一类毛兰素类似物，通过特定的连接子链接两个不同的芳香环、多氢芳环或芳香杂环片段形成的化合物，或其构象异构体、旋光异构体或其盐：所述毛兰素类似物为盐时，为所述结构式与矿物酸或有机酸形成的盐。本发明构建这类新的毛兰素类似物的制备方法操作简单、产率高。新构建的毛兰素类似物具有良好的抗癌活性，且半衰期最长为毛兰素的12余倍，具有良好的制药潜力。
• Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity
  作者：Sylvie Ducki、David Rennison、Meiko Woo、Alexander Kendall、Jérémie Fournier Dit Chabert、Alan T. McGown、Nicholas J. Lawrence

  DOI：10.1016/j.bmc.2009.09.039

  日期：2009.11

  The alpha-methyl chalcone SD400 is a potent inhibitor of tubulin assembly and possesses potent anticancer activity. Various chalcone analogues were synthesized and evaluated for their cell growth inhibitory properties against the K562 human chronic myelogenous leukemia cell line (SD400, IC50 0.21 nM; combretastatin A4 CA4, IC50 2.0 nM). Cell cycle analysis by flow cytometry indicated that these agents are antimitotic (SD400, 83% of the cells are in G(2)/M phase; CA4 90%). They inhibit tubulin assembly at low concentration (SD400, IC50 0.46 mu M; CA4, 0.10 mu M) and compete with [H-3] colchicine for binding to tubulin (8% [H-3] colchicine remained bound to tubulin after competition with SD400 or CA4). Upon treatment with SD400, remarkable cell shape changes were elicited in HUVEC cells, consistent with vasculature damaging activity. (C) 2009 Elsevier Ltd. All rights reserved.